Patent Assignment
Reel/Frame 049106/0137
Release of Security Interest
Recorded: 2019-05-07
Pages: 5
Assignor
VIRTUS GROUP, LP, AS ADMINISTRATIVE AGENT FOR THE LENDERS
Executed: 2019-05-07
Assignee
ANGIOTECH PHARMACEUTICALS, INC.
1100 355 BURRARD STREET, VANCOUVER, B.C., V3C 2G8, CANADA
Covered Properties
(5)
Anti-Angiogenic Compositions and Methods of Use
Patent:
5,886,026 →
Application:
08/472,413 →
Production of Collagen in the Milk of Transgenic Mammals
Patent:
6,713,662 →
Application:
08/482,173 →
Coated Medical Devices with Adhesion Promoters
Application:
12/520,814 →
Publication:
US 2010/0196718
Multifunctional Compounds for Forming Crosslinked Biomaterials and Methods of Preparation and Use
Kit for Multifunctional Compounds Forming Crosslinked Biomaterials
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Sep 4, 2013
From: WELLS FARGO FOOTHILL, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; ANGIOTECH AMERICA, INC.; SURGICAL SPECIALTIES CORPORATION (US), INC., FORMERLY KNOWN AS ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.
Reel/Frame 031157/0186 →
Assignment of Assignor's Interest
Oct 29, 2013
From: ANGIOTECH PHARMACEUTICALS (US), INC.
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 031510/0399 →
Assignment of Assignor's Interest
Oct 26, 2014
From: ANGIOTECH BIOCOATINGS CORP.
To: ANGIOTECH PHARMACEUTICALS (US), INC.
Reel/Frame 034034/0900 →
Security Interest
Dec 7, 2016
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: SILICON VALLEY BANK
Reel/Frame 040839/0865 →
Security Interest
Mar 10, 2017
From: ANGIOTECH PHARMACEUTICALS, INC.
To: VIRTUS GROUP, LP
Reel/Frame 041539/0864 →
Amended and Restated Intellectual Property Security Agreement
May 16, 2017
From: PHARMING INTELLECTUAL PROPERTY B.V.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042481/0139 →
Security Interest
May 26, 2019
From: ANGIOTECH PHARMACEUTICALS, INC.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049288/0184 →
Release of Security Interest
Jan 28, 2020
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: PHARMING GROUP N.V.; PHARMING TECHNOLOGIES B.V.; PHARMING INTELLECTUAL PROPERTY B.V.; BROEKMAN INSTITUUT B.V.
Reel/Frame 051722/0304 →
Release of Security Interest : Recorded at Reel/Frame - 049288/0184
Jan 29, 2021
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 055171/0634 →